Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03738891 · ClinicalTrials.gov registry record · NA
CoolSculpting and EMS for the Abdomen
A NA study of Body Fat Disorder, sponsored by Zeltiq Aesthetics.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 4
- Study locations
NCT03738891 is a NA study of Body Fat Disorder that has completed, run by Zeltiq Aesthetics. The registered enrollment target is 50 participants, above the 32-participant average among 3 other Body Fat Disorder trials with a reported enrollment target (56% higher). The trial reports 4 study locations across 2 states.
The verdict
NCT03738891, a NA study of Body Fat Disorder, has completed, sponsored by Zeltiq Aesthetics.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 4
- Study locations
Study Summary
Evaluate the use of Electromagnetic Muscle Stimulation as an adjunctive treatment to CoolSculpting.
Conditions Studied
Interventions
- DEVICE Zeltiq CoolSculpting System alone
- DEVICE Electromagnetic Muscle Stimulation alone
- DEVICE EMS followed by CoolSculping
- DEVICE CoolSculpting followed by EMS
Study Locations (4)
California
- Marina Plastic Surgery - Marina del Rey
- Innovation Research Center - Pleasanton
- Laser & Skin Surgery Center of Northern California - Sacramento
North Carolina
- Aesthetic Solutions, P.A. - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-11-07 |
| Est. Completion | 2019-09-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03738891
The ClinicalTrials.gov registry entry for NCT03738891 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 32-participant average among 3 other Body Fat Disorder trials with a reported enrollment target (56% higher). The listed sponsor is Zeltiq Aesthetics, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Body Fat Disorder appearing as the primary indexed condition, and to 4 interventions - of which Zeltiq CoolSculpting System alone is the first listed.
NCT03738891 reports 4 study locations spanning 2 distinct geographic areas - top geographies include California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT03738891 about?
NCT03738891 is a clinical study titled "CoolSculpting and EMS for the Abdomen". Evaluate the use of Electromagnetic Muscle Stimulation as an adjunctive treatment to CoolSculpting.
What is the current status of trial NCT03738891?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-11-07. Estimated completion is 2019-09-09.
What conditions does trial NCT03738891 study?
This clinical trial studies the following conditions: Body Fat Disorder.
What interventions are being tested in trial NCT03738891?
The interventions under investigation include: Zeltiq CoolSculpting System alone (DEVICE), Electromagnetic Muscle Stimulation alone (DEVICE), EMS followed by CoolSculping (DEVICE), CoolSculpting followed by EMS (DEVICE).
Who is sponsoring clinical trial NCT03738891?
This trial is sponsored by Zeltiq Aesthetics, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03738891 being conducted?
This trial has 4 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Fat Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.